Knight BioAdvisors provides strategic support to the biopharmacutical industry, specializing in monoclonal antibody-related programs from discovery to IND. Our areas of consulting expertise include:
- Discovery strategies
- Choice of optimal technologies
- Independent expert review of ongoing programs
- Scientific advice on drafting patent applications
- Determination of optimal profiles for potential development candidates
- Strategic approaches to early proof of concept
- Determination of most efficient early development pathways
- Key datasets needed to promote collaboration, partnering, and funding
- Design of key studies and analysis of results
- Outsourcing strategies for discovery and development